Table III.
All Patients (N=550) |
Benign (N=379) |
Borderline (N=108) |
Malignant (N=58) |
P1 | P2 | P3 | P4 | |
---|---|---|---|---|---|---|---|---|
Race | 0.06 | |||||||
White | 326 (59.3%) | 227 (69.6%) | 64 (19.6%) | 34 (10.4%) | ||||
Black/African American | 85 (15.5%) | 61 (71.8%) | 13 (15.3%) | 10 (11.8%) | 0.66 | |||
Asian | 47 (8.6%) | 28 (59.6%) | 16 (34.0%) | 2 (4.3%) | 0.05 | |||
Other | 45 (8.2%) | 27 (60.0%) | 9 (20.0%) | 9 (20.0%) | 0.16 | |||
Not specified/Missing | 47 (8.6%) | 36 (76.7%) | 6 (12.8%) | 3 (6.4%) | ||||
Ethnicity | 0.19 | |||||||
Hispanic/Latina | 37 (6.7%) | 28 (75.7%) | 8 (21.6%) | 1 (2.7%) | ||||
Not Hispanic/Latina | 396 (72.0%) | 258 (65.2%) | 84 (21.2%) | 50 (12.6%) | ||||
Not specified/Missing | 117 (21.3%) | 93 (79.5%) | 16 (13.7%) | 7 (6.0%) | ||||
Race/Ethnicity | <0.001 | |||||||
NH White | 264 (48.0%) | 179 (67.8%) | 53 (20.1%) | 31 (11.7%) | ||||
NH Black/African American | 70 (12.7%) | 47 (67.1%) | 13 (18.6%) | 9 (12.9%) | 0.94 | |||
NH Asian | 38 (6.9%) | 21 (55.3%) | 14 (36.8%) | 2 (5.3%) | 0.05 | |||
NH Other | 18 (3.3%) | 8 (44.4%) | 2 (11.1%) | 8 (44.4%) | 0.002 | |||
Hispanic/Latina | 37 (6.7%) | 28 (75.7%) | 8 (21.6%) | 1 (2.7%) | 0.26 | |||
Not specified/Missing | 123 (22.4%) | 96 (78.1%) | 18 (14.6%) | 7 (5.7%) |
Chi-square test p-value for any differences across all races or all race/ethnicity groups.
Pairwise Chi-square or Fisher’s exact test p-value for difference in specified race vs. White.
Pairwise Chi-square or Fisher’s exact test p-value for difference in specified race/ethnicity vs. NH White.
Fisher’s exact test p-value for difference in Hispanic/Latina vs. Not Hispanic/Latina.
Data presented as N (%) with column percentages for All Patients and row percentages for all other data.
Percentages may not add up to 100 due to rounding or missing values.
NH=Non-Hispanic.